药物基因组学临床决策支持:范围综述
最常见工具为检测后中断性警报,临床应答率12-73%,警报应答率21-98%,但关于指标随时间变化及驱动系统优化的数据较少。
要点
- 检测后中断性警报是最广泛研究的药物基因组学临床决策支持方法。
- 临床应答率范围为12-73%,警报应答率范围为21-98%。
- 关于药物基因组学临床决策支持可用性、有效性和优化的研究仍不足。
核心结论
- 检测后警报是研究最广泛的药物基因组学临床决策支持方法,但其有效性差异很大。
- 需要进一步研究药物基因组学临床决策支持工具的可用性、有效性和优化。
研究设计与样本
- 范围综述,检索并筛选描述药物基因组学电子临床决策支持工具并报告相关指标的文章。
主要发现
- 临床决策支持实施中最常见的工具是检测后中断性警报。
- 临床应答率范围为12-73%,警报应答率范围为21-98%。
- 关于指标随时间变化及驱动临床决策支持系统演变的措施的数据较少。
关键数值与推荐
- 纳入标准:(i)描述药物基因组学电子临床决策支持工具;(ii)报告与药物基因组学临床决策支持相关的指标。
临床怎么用
- 临床实施药物基因组学临床决策支持时可参考检测后中断性警报策略,但需注意其有效性变异较大。
- 应关注临床应答率和警报应答率等指标以评估临床效用。
局限性
- 关于药物基因组学临床决策支持最佳方法的支持数据相对较少。
- 纳入研究中93%的项目位于学术医学中心,可能限制结果外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical decision support (CDS) is often cited as an essential part of pharmacogenomics (PGx) implementations. A multitude of strategies are available; however, it is unclear which strategies are effective and which metrics are used to quantify clinical utility. The objective of this scoping review was to aggregate previous studies into a cohesive depiction of the current state of PGx CDS implementations and identify areas for future research on PGx CDS. Articles were included if they (i) described electronic CDS tools for PGx and (ii) reported metrics related to PGx CDS. Twenty of 3,449 articles were included and provided data on PGx CDS metrics from 15 institutions, with 93% of programs located at academic medical centers. The most common tools in CDS implementations were interruptive post-test alerts. Metrics for clinical response and alert response ranged from 12-73% and 21-98%, respectively. Few data were found on changes in metrics over time and measures that drove the evolution of CDS systems. Relatively few data were available regarding support of optimal approaches for PGx CDS. Post-test alerts were the most widely studied approach, and their effectiveness varied greatly. Further research on the usability, effectiveness, and optimization of CDS tools is needed.
引用
- Smith DM, Wake DT, Dunnenberger HM, et al. Pharmacogenomic Clinical Decision Support: A Scoping Review. Clin Pharmacol Ther. 2022. PMID: 35838358. doi:10.1002/cpt.2711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。